The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Howard S. Hochster

New York University Medical Center

New York

NY 10016

USA

[email]@med.nyu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • New York University Medical Center, New York, NY 10016, USA. 2001 - 2009
  • Division of Medical Oncology, New York University School of Medicine, NYU Cancer Institute, NY 10016, USA. 2003 - 2008
  • New York University, New York, USA. 2000
  • Kaplan Cancer Center and New York University Medical Center, New York, and Albert Einstein College of Medicine, Bronx, USA. 1999

References

  1. Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 Study. Hochster, H., Weller, E., Gascoyne, R.D., Habermann, T.M., Gordon, L.I., Ryan, T., Zhang, L., Colocci, N., Frankel, S., Horning, S.J. J. Clin. Oncol. (2009) [Pubmed]
  2. Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study. Hochster, H., Chen, T.T., Lu, J.M., Hills, D., Sorich, J., Escalon, J., Ivy, P., Liebes, L., Muggia, F. Gynecol. Oncol. (2008) [Pubmed]
  3. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. Hochster, H.S., Hart, L.L., Ramanathan, R.K., Childs, B.H., Hainsworth, J.D., Cohn, A.L., Wong, L., Fehrenbacher, L., Abubakr, Y., Saif, M.W., Schwartzberg, L., Hedrick, E. J. Clin. Oncol. (2008) [Pubmed]
  4. Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299. Hochster, H.S., Luo, W., Popa, E.C., Lyman, B.T., Mulcahy, M., Beatty, P.A., Benson, A.B. J. Clin. Oncol. (2007) [Pubmed]
  5. Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG study. Hochster, H.S., Plimack, E.R., Mandeli, J., Wadler, S., Runowicz, C., Goldberg, G., Speyer, J., Wallach, R., Muggia, F. Gynecol. Oncol. (2006) [Pubmed]
  6. Bevacizumab in combination with chemotherapy: first-line treatment of patients with metastatic colorectal cancer. Hochster, H.S. Semin. Oncol. (2006) [Pubmed]
  7. Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group. Hochster, H., Plimack, E.R., Runowicz, C.D., Speyer, J., Wallach, R.C., Sorich, J., Mandeli, J., Wadler, S., Wright, J., Muggia, F.M. J. Clin. Oncol. (2004) [Pubmed]
  8. The role of pemetrexed in the treatment of gastrointestinal malignancy. Hochster, H.S. Clin. Colorectal. Cancer (2004) [Pubmed]
  9. Newer approaches to gemcitabine-based therapy of pancreatic cancer: fixed-dose-rate infusion and novel agents. Hochster, H.S. Int. J. Radiat. Oncol. Biol. Phys. (2003) [Pubmed]
  10. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer. Hochster, H., Chachoua, A., Speyer, J., Escalon, J., Zeleniuch-Jacquotte, A., Muggia, F. J. Clin. Oncol. (2003) [Pubmed]
  11. Activity and safety of vinorelbine combined with doxorubicin or fluorouracil as first-line therapy in advanced breast cancer: a stratified phase II study. Hochster, H.S., Vogel, C.L., Burman, S.L., White, R. Oncologist (2001) [Pubmed]
  12. Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group. Hochster, H.S., Oken, M.M., Winter, J.N., Gordon, L.I., Raphael, B.G., Bennett, J.M., Cassileth, P.A. J. Clin. Oncol. (2000) [Pubmed]
  13. Activity and pharmacodynamics of 21-Day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy. New York Gynecologic Oncology Group. Hochster, H., Wadler, S., Runowicz, C., Liebes, L., Cohen, H., Wallach, R., Sorich, J., Taubes, B., Speyer, J. J. Clin. Oncol. (1999) [Pubmed]
 
WikiGenes - Universities